Uniqure NVNASDAQ:QURE
- LAST PRICE4.4650
- TODAY'S CHANGE (%)-0.0150 (-0.3348%)
- Bid / Lots4.4600/ 1
- Ask / Lots4.4700/ 3
- Open / Previous Close4.4400 / 4.4800
- Day Range
- 52 Week Range
- Volume252,190
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | QURE |
|---|---|---|
| 09:32 ET | 3022 | 4.44 |
| 09:36 ET | 500 | 4.4801 |
| 09:38 ET | 2862 | 4.48 |
| 09:39 ET | 1105 | 4.51 |
| 09:41 ET | 1110 | 4.57 |
| 09:45 ET | 1800 | 4.55 |
| 09:48 ET | 200 | 4.55 |
| 09:50 ET | 6742 | 4.555 |
| 09:52 ET | 1628 | 4.57 |
| 09:54 ET | 1000 | 4.56 |
| 09:56 ET | 2553 | 4.57 |
| 09:59 ET | 3200 | 4.54 |
| 10:01 ET | 1100 | 4.543 |
| 10:03 ET | 1310 | 4.54 |
| 10:06 ET | 4418 | 4.5507 |
| 10:08 ET | 1292 | 4.57 |
| 10:10 ET | 362 | 4.56 |
| 10:12 ET | 4100 | 4.5 |
| 10:14 ET | 400 | 4.5 |
| 10:15 ET | 800 | 4.495 |
| 10:17 ET | 756 | 4.515 |
| 10:19 ET | 100 | 4.515 |
| 10:21 ET | 100 | 4.505 |
| 10:24 ET | 200 | 4.5 |
| 10:28 ET | 200 | 4.51 |
| 10:30 ET | 100 | 4.51 |
| 10:32 ET | 3800 | 4.485 |
| 10:33 ET | 2561 | 4.505 |
| 10:35 ET | 1684 | 4.53 |
| 10:37 ET | 1600 | 4.539 |
| 10:39 ET | 600 | 4.5407 |
| 10:42 ET | 100 | 4.54 |
| 10:44 ET | 1135 | 4.54 |
| 10:46 ET | 329 | 4.515 |
| 10:48 ET | 665 | 4.525 |
| 10:50 ET | 4756 | 4.495 |
| 10:51 ET | 100 | 4.49 |
| 10:53 ET | 5243 | 4.46 |
| 10:55 ET | 1557 | 4.465 |
| 10:57 ET | 5319 | 4.485 |
| 11:00 ET | 723 | 4.505 |
| 11:02 ET | 400 | 4.505 |
| 11:06 ET | 700 | 4.52 |
| 11:08 ET | 4200 | 4.5194 |
| 11:09 ET | 25553 | 4.535 |
| 11:13 ET | 100 | 4.535 |
| 11:15 ET | 1710 | 4.515 |
| 11:18 ET | 1163 | 4.515 |
| 11:20 ET | 1412 | 4.505 |
| 11:22 ET | 964 | 4.5 |
| 11:24 ET | 100 | 4.49 |
| 11:26 ET | 431 | 4.49 |
| 11:27 ET | 200 | 4.495 |
| 11:29 ET | 300 | 4.49 |
| 11:31 ET | 14944 | 4.495 |
| 11:33 ET | 30573 | 4.505 |
| 11:36 ET | 200 | 4.505 |
| 11:38 ET | 1066 | 4.485 |
| 11:40 ET | 1000 | 4.495 |
| 11:42 ET | 1900 | 4.49 |
| 11:44 ET | 500 | 4.485 |
| 11:45 ET | 500 | 4.495 |
| 11:47 ET | 3899 | 4.5056 |
| 11:49 ET | 600 | 4.51 |
| 11:51 ET | 4142 | 4.515 |
| 11:54 ET | 100 | 4.515 |
| 11:56 ET | 2982 | 4.54 |
| 11:58 ET | 12500 | 4.54 |
| 12:02 ET | 1326 | 4.53 |
| 12:03 ET | 400 | 4.525 |
| 12:05 ET | 200 | 4.525 |
| 12:07 ET | 200 | 4.525 |
| 12:09 ET | 500 | 4.53 |
| 12:12 ET | 9895 | 4.515 |
| 12:14 ET | 2125 | 4.485 |
| 12:16 ET | 100 | 4.485 |
| 12:18 ET | 215 | 4.48 |
| 12:20 ET | 100 | 4.485 |
| 12:21 ET | 100 | 4.485 |
| 12:23 ET | 600 | 4.495 |
| 12:25 ET | 900 | 4.495 |
| 12:27 ET | 100 | 4.495 |
| 12:32 ET | 1674 | 4.475 |
| 12:34 ET | 100 | 4.475 |
| 12:36 ET | 100 | 4.475 |
| 12:38 ET | 200 | 4.47 |
| 12:39 ET | 100 | 4.475 |
| 12:41 ET | 200 | 4.475 |
| 12:43 ET | 100 | 4.475 |
| 12:45 ET | 300 | 4.475 |
| 12:48 ET | 2139 | 4.49 |
| 12:50 ET | 400 | 4.495 |
| 12:52 ET | 4243 | 4.45 |
| 12:54 ET | 200 | 4.45 |
| 12:56 ET | 100 | 4.455 |
| 12:57 ET | 100 | 4.455 |
| 12:59 ET | 2848 | 4.455 |
| 01:01 ET | 700 | 4.465 |
| 01:03 ET | 1000 | 4.45 |
| 01:06 ET | 900 | 4.46 |
| 01:08 ET | 100 | 4.465 |
Today
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesPress Release: uniQure Announces Sale of Commercial Manufacturing Facility to Genezen, from 6 hours ago by Dow Jones
6 hours ago by Dow Jones*DJ Genezen To Acquire UniQure's Commercial Gene Therapy Manufacturing Operations In Lexington, MA QURE, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesGenezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesuniQure Announces Sale of Commercial Manufacturing Facility to Genezen, from 6 hours ago by Dow Jones
6 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Uniqure NV | 217.5M | -0.7x | --- |
MeiraGTx Holdings PLC | 270.7M | -3.2x | --- |
Lineage Cell Therapeutics Inc | 188.3M | -7.1x | --- |
TriSalus Life Sciences Inc | 149.9M | -2.6x | --- |
Fennec Pharmaceuticals Inc | 166.9M | 172.3x | --- |
Mediwound Ltd | 144.1M | -11.3x | --- |
Company Information
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Contact Information
- Headquarters
- Paasheuvelweg 25aAMSTERDAM, Netherlands 1105 BP
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- David Meek
- Chief Executive Officer, Executive Director
- Matthew Kapusta
- Chief Financial Officer
- Christian Klemt
- Chief Operations Officer
- Pierre Caloz
- Chief Business and Scientific Officer
- Richard Porter
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $217.5M |
|---|---|
Revenue (TTM) | $19.0M |
Shares Outstanding | 48.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.96 |
EPS | $-6.20 |
Book Value | $4.34 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 11.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,383.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
